Options Trading Strategies

Options trading news

Options Trading Strategies

Read the September 14, 2015 — Where To Invest September 2015 Newsletter in .pdf format – Click Here

Option Trade Alerts Service and

Options Trading Strategies Newsletter

with Stock Options Trade Alerts,

How To Trade Options and

Options Trading Strategies That Work

 Options Trading Strategies

September 14, 2015

Market Strategies Newsletter

Sample Issue

Balanced Investing Strategies To Make Money In Up Or Down Markets

A Publication of Princeton Research, Inc. (www.PrincetonResearch.com)

Contributing Staff: Michael King, Charles Moskowitz


Where To Invest In 2015 Newsletter Covering:

Where to Invest September 2015

Best Stocks To Buy September 2015

Stock Market Investing Strategies

Stock Options Trade Alerts

Options Trading Strategies

How To Trade Options


2015 YTD Profits $ 7511

Over 75% Returns


2014 Profits = $ 20,443

Over 204% Returns


NOTE: This is a Sample Issue Only!



Visit: PrincetonResearch.com/join.htm


For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To: PrincetonResearch.com/alerts.htm

Where To Invest Your Money Now
Where To Invest Your Money Now

Charles Moskowitz Discussion


We have 1 open long position:


YRWC  September 17.50 Puts


Funds in Use   $ 620


Week 37 was characterized by complete and total inaction.  I tried to find a spot on that I was comfortable to be a buyer, and after not getting fills at my prices, I backed off. Wednesday I tried to find some puts early and again didn’t get anything done.  So I did nothing…”When in Doubt stay out.”


The performance in this account is not based on taking undue risks, but rather being in positions that have a right or right out bent where if we are right, we profit handsomely and if we’re wrong we control the loss by either the 50% Down rule or a stop.


As far as the markets were concerned it has been a wide range, no change affair since the big break of three weeks ago.  The good news is that we are getting the kind of horizontal action I mentioned here last week and the week before.  We are getting a boring trading range on a weekly basis that can help to define the risks.


I am surprised that consumer confidence has waned in front of the back to school season. The retailers were again cutting prices and it will be a little while yet before we see if there is an effect on their bottom line.  You would think that with gas prices so much lower that they would have had some excess cash in their pockets.  My local stations price of $2.13 looks awfully good since just 4 months ago it was $3.00…..


All this action this week will be about the Fed decision.  Depending on how you view it, we will either be pleased that the Fed has finally made its well anticipated first move, or its “one and done” move on rates.


Clearly the inflation data and international worries such as weakness among European countries with their immigration problems or trading partners who have weak currencies like China and others that are commodity based such as Brazil and Nigeria is the problem…we have none judged by what most of the traditional Fed methods…..If you do your own food shopping you see the inflation, but they don’t.


The problem as viewed by the pundits is that if they are wrong, we suffer with nothing left in their bag of tricks to help stimulate the economy.  Clearly we are nowhere near an overheated economy….If you look at revenues instead of profits it’s pretty clear.  One thing for sure, If I get a chance to short volatility, I will make that trade, since once the news is actually out the crush of the indecision will work its way through the market….CAM

where to invest your money now


Market Strategies $10,000 Trading Account Trade Table


New Trades


1)  Buy 8 CWST December $ 5 Calls @ $ 0.95 O.B.


Bought 4 YRWC Sept 17.50 Puts
Last Week
Sold 2 SPY Sept 202 Calls
      194 Loss
Sold 2 AAPL Sept 4th 106 Puts
 ( 50% Loss Rule )
      100 Loss
Sold 3 AAPL Sept 4th 106 Puts
 ( 100% Profit Rule )
      300 Gain
Bought 4 YRWC Sept 17.50 Puts
Bought  2 Sept  202  Calls
Bought  5 AAPL Sept 4th 106 Puts


Remember, these trades are based on your participation in the

Subscriber Members Only




Previous closed out trades not listed here may be seen in previous market letters in the

VIP Subscribers Members Area.


For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To: PrincetonResearch.com/alerts.htm


MARKET Laboratory – Weekly Changes

Prices are copied from Barron’s Weekly and Yahoo Finance and may be incorrect.









S&P 500








Russell 2000








Gold (spot)












Heating Oil




Unleaded Gas




Natural Gas








Put/Call Ratios

S&P 100



Put/Call Ratios

CBOE Equity





154-26 -1-00

2.95% +0.06%

10 Yr. Note

127-17-07         2.19% -05%






CRB Inflation





Barron’s* Confidence







5 Yr. Note

119-232 -03

1.51% +0.05%






DJ Utilities








34.7 %








M1 Money  Supply


Aug 31st

M-2 Money



Aug 31st



* Component Change in the Confidence Index


M1…all money in hands of the public, Time Deposits Traveler’s Checks, Demand Deposits
M2.. adds Savings and Money Market Accounts both compared with the previous year.


Where to invest sepetember 2015 stocks to buy

Market Strategies Technical Information


Support/Resistance Levels:                SUPPORT                         RESISTANCE


S&P 500             1888                                  1.998

Dow                  15,840                               16,680

QQQ                  99.40                                106 60

Transports        7800                                     8177

NASDAQ          4590                                   4870


$100,000 Trading Portfolio Stock Positions and Trades


Each stock is allocated a theoretical $ 5,000 share of the portfolio unless otherwise indicated.           





Purchase Price Purchase Date Stop/Loss   Price/Date Sold   Profit/


NUGT 1200 2.77       09/09 2.56   09/11 ( $ 252 )
AMBA 80 74.14       09/04      68.98 68.98 09/09 ( $ 412 )
MOS  100 43.55       08/14
SNSS 1200   2.95       06/26        0.98
DSX  500   7.05       05/18
CRM  100 72.90       04/29      66.25
GILD  50 102.73       03/03    100.45
ARRY 500   8.02       02/24        5.12
NAT   300

Sold 200

10.16       02/13 14.40  06/25    $ 848
NBG  600 1.40       02/17
BAC. Wts 5,000 lots 0.7411       12/26
BSBR  500






SAN  600 8.40      12/16
AA  500 14.21      10/16
FCX 150 34.99      09/09    7.75
NBG 300   2.95      05/19
RPTP 200

Sold 200

15.37      01/16 16.09  06/25   $ 144
NBG 300 4.08 8/12
TEXQY* 200 6.56 7/11
REPR* 5000 0.22 10/22/12


Remember, these trades are based on your participation in the

Subscriber Members Only




Previous closed out trades not listed here may be seen in previous market letters in the

VIP Subscribers Members Area.


NOTE: This is a Sample Issue Only!




Visit: PrincetonResearch.com/join.htm




For those of you who do not buy puts to protect your portfolio, there are many ETF’s that are the inverse of the DOW. The symbols are DOG, DXD, SDS,TZA and RWM, which go up when the  DOW, S&P 500 and Russell 2000 go down and down when they go up. The DZZ goes up double when gold goes down.



Market Strategies $100,000 Trading Account


New Options Trades:


There were no closed option positions.


There were two closed out stock positions:


80 AMBA for a loss of $ 412 and the

NUGT stopped out with a loss of $ 252.


For the year to date we have gains of $ 21,396. 


Open position losses decreased to  $ 13,638.


The options expire on the third Friday of each Month unless otherwise posted.


The Stock table has the following 19 positions:


AA,  ARRY,  BAC.B.WS,  BSBR( 2 ) , CRM,  DSX, FCX,



The options call for a $ 2,500 investment unless otherwise stated; each stock position requires $5,000 unless otherwise mentioned specifically


We are basing money management on a hypothetical $ 100,000

and are using a total of $61,196

for the 19 open stock positions. There is one long option position requiring $ 1,240

totaling $ 62,436,

leaving $ 37, 564 in cash.


These figures are approximate and there might be errors.


We have not counted the dividends received from Apple, JP Morgan, North American Tankers, Santander, their Brazil affiliate BSBR and  Blue Capital Reinsurance which was sold for a profit

and many others.


Executions that have occurred at or near the open or close of trading sometimes vary from our actual numbers.  For example, when something opens down and it is through our price, we take the next trade whether it is an uptick or continues lower.  This sometimes results in a 50% trade that is slightly above or below the exact number.



Previous Week’s Recommendations and

Rules for the Market Strategies

$100,000 Portfolio Trading Account


  • All options count for about $ 2,500.00 for model portfolio calculations unless

otherwise stated


  • When the option has doubled sell half the position


  • Stop Loss protection is either half or offered with each trade


  • The cost of the option is the asking price (or the price between the bid and ask,

whichever is more realistic)


  • The options will be followed until closed out.


  • Option Symbols are stock symbol with expiration month and strike price



Option           COST Date Sold Date Profit/(Loss)
YRCW Sept 17.50  8 lots    Calls





Remember, these trades are based on your participation in the

Subscriber Members Only




Previous closed out trades not listed here may be seen in previous market letters in the

VIP Subscribers Members Area.


For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To: PrincetonResearch.com/alerts.htm


This Weeks’ Economic Numbers

Earnings Releases and Media Data


Before the Open on top of the Row;

After the close below the Economics Information


MONDAY European Union Members hold an extraordinary meeting to talk about proposals on the refugee crisis.


Rosh Hashanah the Jewish  new year begins through Tuesday.

Trading will be subdued.

Israel markets will be closed.

TUESDAY Netsol  NTWK ( -0.15 vs -0.79 )

08:30 hrs  Retail Sales August ( 0.3% vs 0.6% )

Retail Sales Ex-Auto ( 0.2% vs 0.4% )

09:15 hrs  Industrial Production August ( -0.2% vs 0.6% )

Capacity Utilization August ( 77.8% vs 78.0% )

Aviat Networks  AVNW  ( 0.00 vs -0.13 ) United Natural Foods 0.72 vs 0.67

WEDNESDAY FedEx FDX ( 2.46 vs 2.10 ) Cracker Barrel CBRL ( 1.86 vs 1.63 ) Ascena Retail Group  ASNA ( 0.05 vs 0.13 ) Lightin The Box Holding LITB ( -0.07 vs -0.11 )

The Federal Reserve’s Federal open Market Committee begins a two-day meeting.

Both Radio Shack and Patriot Coal seek bankruptcy court approval to repay creditors and restructure.

07:00 hrs  MBA Mortgage Index  09/12   ( NA vs -6.2% )

08:30 hrs CPI August ( -0.1% vs 0.1% )

CORE CPI ( 0.1% vs 0.1% )

10:30 hrs Crude Inventories 09/12 ( NA vs 2.570 Mln Bbls )

16:00 hrs Net Long Term TIC Flows July ( NA vs + $ 103.0 Bln )

Oracle ORCL ( 0.52 vs 0.62 ) Herman Miller MLHR ( 0.47 vs 0.47 )

THURSDAY Rite Aid RAD ( 0.05 vs 0.13 ) Marcus MCS ( 0.51 vs 0.45 ) Manchester United MANU (  -0.09 vs -0.04 )

08:30 hrs Initial Claims 09/12  ( 275K vs  275K )

08:30 hrs Continuing Claims 09/05  ( 2254K vs 2260K )

08:30 hrs Housing Starts August ( 1160 vs 1206 )

Building Permits August ( 1159 vs 1119 )

08:30 hrs Current Account Balance 2nd Qtr ( -$112.2B vs -$ 113.3 B )

10:00 hrs Philadelphia Fed September ( 6.5 vs 8.3 )

10:30 hrs Natural Gas Inventories 09/12  ( NA vs 68 bcf )

14:00 hrs FOMC Rate Decision and Discussion Janet Yellen will hold a post-meeting news conference.

Adobe Systems ADBE ( 0.50 vs 0.28 ) MCBC Holdings MCFT ( 0.19 )

FRIDAY Zayo Group Holdings ZAYO ( 0.04 )

10:00 hrs Leading Economic Indicators August ( +0.2% vs -0.2% )


 Where to invest in 2015

Market Strategies Fundamentals


The DJ Transportation Average led all indexes gaining 257.79 points or 3.31%. Nasdaq followed with a nice gain of 138.42 points or 2.96%. The S&P 500 added 39.83 or 2.07%, while the Dow improved by 330.71 points or 2.05%.


The FOMC  meets Wednesday and Thursday. There is no clear consensus on Wall Street about whether they will raise rates. Volatility has been huge while while the indexes have flip-flopped from gains to losses and back again for 10 straight weeks. A pessimistic streak runs through the market as investors have pulled

$ 16.2 billion out of equity funds in the week ended September 9th according to Lipper. A Merrill Lynch analysis estimates that outflows have totaled $ 46 billion over 4 weeks.




While stock markets have demonstrated uncertainty, the economic fundamentals in the U.S. have remained strong as evidenced by the above chart. Wealthy investors are pouring funds into U.S. assets.  TIC Flows are expected to continue strong following June’s $ 103 Billion in receipts. The Net Long-Term TIC Flows is released by the US Department of Treasury. TIC stands for Treasury International Capital. It shows in and out flows of financial resources in the United States. The TIC flows is one of the major events in the market, as it is seen by most participants as the Government resource for offsetting the current Trade Deficit.

All indicators have been strong for the U.S. economy including industrial production. Industrial production increased 0.6% in July after increasing a downwardly revised 0.1% (from 0.2%) in June. The Briefing.com Consensus expected industrial production to increase 0.3%. Still a multitude of stock traders are betting that the economy is topping and the stock market is turning down at a time when interest rates are likely to go higher.

Their argument is not illogical. The S&P 500 made a low March 11, 2009 at 666.79 and has recently rallied to a high of 2134.71 reached on May 20, 2015 only to set back to 11867.61 a decline of 12.5% on August 25th with a rebound to 1961.05 currently, a decline of 8.13% all calculated from the highs. The uncertainty has caused extreme volatility which some economists call “ dumb money.” The reason is that as one can visualize from the above chart the high  volatility never lasts.


Market Strategies Economic Data


Producer prices in the U.S. were flat in August after rising 0.2% in July. The Briefing.com consensus had expected the headline PPI to fall 0.1%. The CORE PPI, which excludes the volatile food and energy prices rose 0.3% following a similar rise in July. Widening profit margins at clothing retailers drove the jump.


The University of Michigan Consumer Sentiment Index fell to 85.7 in the preliminary September reading from 91.9 in the last reading of the prior month. The Briefing consensus called for 91.5. That was the lowest reading of the Consumer Sentiment Index since it reached 84.6 in September 2014. At that time however, sentiment was trending upwards. The Current Conditions Index fell to 100.3 in September from 105 in August. The Expectations Index declined to 76.4 from 83.4.


The overall decline in the Consumer Sentiment Index can be traced to the sharp retraction in stock prices which began at the end of August. Other measure that typically impact confidence levels such as gasoline prices and employment conditions continued to improve over the past few weeks but were overshadowed by the huge velocity of falling stock prices.



The Treasury Budget showed a deficit of $ 64.4 Bln in August, sharply down from a deficit of $ 128.7 Bln in August 2014. Receipts are trending well above outlays as the current conditions bode well to trim the deficit.


Job Openings JOLTS again rose to a series high of 5.8 million on the last business day of July. The prior series high was 5.4 million in May 2015. The series began in December 2000.


The job openings rate for July rose to 3.9% after measuring 3.6% in the prior

3 months. Several industries experienced a rise in openings: Professional and Business services grew by 122,000. Food services and accommodations added 82,000; Retail trade added 77,000 and Nondurable Goods Manufacturing + 27,000. Regionally, the number of job openings in the Northeast grew by 154,000 and the South 141,000.


The number of layoffs and discharges increased in mining by 8,000 and in federal government 5,000. Hires and separations edged down to 5.0 million, respectively. The quits rate was 1.9% for the fourth month in a row, while layoffs and discharges rate declined to 1.1%. The results for August will be released Friday October 16th.

Producer prices were flat in August after increasing 0.2% in July. The Briefing.com Consensus expected the PPI to decline 0.1%.Excluding food and energy, core PPI increased 0.3% for a third consecutive month in August. The consensus expected these prices to increase 0.1%.However,energy prices declined 3.3% in August, which was the largest decline since a 10.1% drop in January, after declining 0.6% in July. The decline in energy prices was mostly the result of a 7.7% decline in gasoline costs.



Market Strategies Cycles


Crude prices tend to peak along with the end of summer. Driving season and hurricane problems tend to come to an end which is an obstacle to demand while supple continues to abound. Seasonal direction is highlighted in yellow.



Shorting the February crude oil futures contract in mid-September and holding until on or about December 9 has produced 21 winning trades in the last 32 years. This gives the trade a 65.6% success rate and theoretical total gains of $99,860 per futures contract. Following three consecutive years of losses, this trade has been successful for three years straight. A sizable portion of last year’s crude collapse from over $100 a barrel in June to the lows in January was captured by this trade resulting in its second best profit to date.





Looking at the above charts, it appears that typical early-fourth-quarter-pre-election-year weakness has arrived early this year (Seventh Years are heavily influenced by the crash of 1987). A retest of the August low is likely. Provided the outlook for global growth does not deteriorate further, history suggests a fourth quarter turn around for the market.


Depending on data source, Q2 earnings were flat or negative and Q3 is currently forecast to be even weaker. Crumbling commodity prices are fueling fresh new deflation concerns. For the time being, the U.S. economy has largely managed to shrug off falling global growth. At some point, it may no longer be able to do that.


Since 1950, September is the worst performing month of the year for DJIA, S&P 500, NASDAQ (since 1971) and Russell 1000 (since 1979). Beneficial pre-election-year forces do little to change this. Depending on index, September is still the worst or second worst month of pre-election years, negative across the board.

September’s first 11 trading days have a rather bullish bias with 7 of these days garnering usually a bull icon for being up 60% or more of the time on the S&P 500 the last 21 years. Since September 1st the S&P 500 has gone from a low of 1903.07 to 1961.05. resistance looms at 1996 while support remains at 1890.


The big question and uncertainty this week hinges on the Fed rate decision. Will the Fed raise rates? The stated economic conditions in the U.S. have been met.

The Unemployment rate has dropped to 5.1%, the stated objective of the easing policy.  Worries abound concerning the world-wide economy and the market reactions both domestically and its effect on the dollar. If the Fed Funds rate were raised, after an immediate downside which would coincide with the seasonal weakness, removing uncertainty would likely be a positive for the fourth quarter and reduce inflamed volatility. A Fed delay merely kicks the can down the road and prolongs the inevitability of higher interest rates.




Undervalued Small Cap Stocks


RMS Medical Systems, Inc ( REPR 0.31 )*  . RMS Medical Products is a U.S. manufacturer of proprietary and patented medical  devices  world-wide which maintains offices and manufacturing facilities in Chester, NY.  For more than three decades, the company has been a leading innovator in the medical device industry in the development and production of proprietary devices and supplies. Principal products include  the Freedom 60 Syringe Infusion System, RMS High-Flo Subcutaneous Safety Needle Sets and the RES-Q-VAC Medical Suctioning Pump. In addition to being regulated by the FDA which has the authority to approve medical devices for marketing in the U.S., RMS complies with ISO International standards for quality development and manufacturing. RMS Medical Products is a d/b/a of Repro-Med Systems, Inc which was founded in 1980.


The Freedom60 has a proprietary technology that makes it desirable for the delivery of medications

In a variety of  therapies.  It is very popular for the delivery of subcutaneous immunoglobulin for the treatment of primary immune deficiency disease. The infusion pump uses “ dynamic equilibrium”

which safely adjusts the flow of medication in accordance with what the patient’s body can accept.

This minimizes complications often encountered with other infusion systems which can lead to site reactions and discomfort for the patient. The portability and simple operation of the FREEDOM60

Improves  quality of life for patients who otherwise might have to use a complicated electronic pump mounted to a cumbersome infusion pole. Patients then don’t have to be confined.

RMS High-Flo Subcutaneous Safety Needle Sets are being welcomed by healthcare providers and patients alike for their consistently high quality. The infusion sets are an ideal companion for the company’s FREEDOM 60 pump, but can be used with any manufacturer’s infusion pump as well.


RES-Q-VAC is a hand-held suction pump used to clear a patient’s airway or for other purposes when reliable hospital quality suctioning is needed. It uses patented technology to protect users from airborne pathogens and spillage of suctioned material. It is used by emergency service personnel and other first responders, as well as in hospitals and other institutions. There also is a version for use by dentists. RES-Q-VAC is invaluable in the event  of disasters where power is lost because it doesn’t require electricity.


The Freedom 60 Syringe Infusion System is a method for administering medication through a small needle to the subcutaneous tissue, which is the fatty tissue just under the skin. Subcutaneous infusion allows medication into the vascular system more slowly. Combined with more frequent delivery this provides more consistent and stable blood levels. The elimination of large swings in these levels decreases side effects improving overall quality of life. RMS provides High-Flo needles to optimize liquid flow. Their smaller 26 gauge high flow needle flows at the same rate as the considerably larger 24 gauge needles,  which are considerably less painful when entering the skin.

The needle sets are patented and approved by the FDA. There has not been a new technology in needles other than Repro Med’s vastly better needle sets in quite some time.


The Freedom 60 has had great success in Europe reflected in a huge sales increase  of  47.8% first quarter 2015 up from same quarter 2014.


Repro-Med Systems, Inc has had an increase in sales each of the last four years. They finished the year of 2014 with $ 11.2 million in sales reflecting top line growth of  29% from 2013.In each of the previous two years they had a 12% increase in sales. The company has had at least $ 700 thousand of net income in each of the past four years and has no debt. The patented needle sets alone can give the company a huge growth potential. In my opinion, with new products coming on stream, the stock should trade between $ 3 and $ 8 in the next two years.


Immune Therapeutics, Inc. (  IMUN 0.23  )*

Buy now. IMUN

Naltrexone is an opioid antagonist used primarily in the management of alcohol and opioid dependence; the FDA approved Naltrexone in 1984 at 50mg. However, in much lower doses there is “Accumulating evidence suggests LDN can promote health supporting immune-modulation, which reduces various oncogenic inflammatory autoimmune processes.

The value of Naltrexone as an immune modulator was recognized by Dr. Ian Zagon at the University of Pennsylvania.2,3 The late Dr. Bernard Bihari, a Neurophysician from New York, USA (who passed away on May 16th, 2010) began treating his patients in the late 1980s4,5. Since that time, many doctors throughout the United States prescribe LDN for a number of indications including Multiple Sclerosis (MS), Parkinson’s disease, Crohn’s disease, HIV/AIDS, cancer and other autoimmune and inflammatory diseases.

A number of research and clinical trials have been completed and undergone in regards to LDN immunotherapies, with phase I and phase II clinical trials successfully run at a number of universities in the United States and Europe, including Pennsylvania State University Medical School at Hershey; University of Chicago; State University of New York; SUNY Upstate Medical University; London Health Sciences Centre – University Hospital, USA; Alpert Medical School of Brown University; Department of Neurology, San Raffaele Scientific Institute; Division of Rheumatology, St. Louis College of Pharmacy; Department of Internal Medicine, University of Utah; Jondi-Shapoor University of Medical Sciences; Department of Psychiatry & Behavioral Sciences, Duke University Medical Center; and Multiple Sclerosis Center at UCSF6. These efforts were pioneered by leading immunologists Dr. Nicholas Plotnikoff, Dr. Ronald Herberman, Dr. Bernard Bihari, Dr. Angus Dalgleish, Dr. Ian S. Zagon, Dr. Jill Smith, Dr. McLaughlin, Dr. Jacqueline McCandless, and Moshe Rogosnitzky, among others.


The mechanism of action of naltrexone, in autoimmune diseases and cancer, is still being researched, but there are theories as to the mechanism of action that both explain why LDN works on both autoimmune diseases and cancers, as well as inflammatory disease.

According to Mark J. Donahue’s paper on LDN that uses interviews from Dr. David, Gluck, Dr. Jacquelyn McCandless, Dr. Jarred Younger, and Dr. Ian Zagon:

“LDN is an opioid antagonist that not only blocks the reception of opiates, but also the body’s own endogenous opioids – endorphins. However, because LDN is administered in such a ‘low dose’ it is believed that LDN only briefly (for 3-4 hours) obstructs the effects of endorphins. Sensing an endorphin deficit, the hypothalamus signals for increased production of endorphins in what is called ‘the rebound effect.’ The rebound effect results in three things happening:

The study of immune cell glial interactions is in its infancy. Glial cells are the immune cells in your central nervous system (brain, spinal cord). They are very involved in dysregulation of pain systems, neuroinflammation, and some neurological diseases such as Multiple Sclerosis, Alzheimer’s, Parkinson ’s disease, Autism, ALS, infections of the brain.

LDN has treated Crohn’s Disease, HIV/Aids, Multiple Sclerosis, Autism, Fibromyalgia, Prostate Cancer, Hepatoblastoma, Gastrointestinal Disorders, Melanoma, Gulf War Syndrome , based on clinical studies and patient data.

Recently the company received it’s first  license to sell their drug in Nigeria. The potential revenues could be just in Nigeria alone over 50 million plus. . There world -wide potential is unlimited and could exceed 2-3 hundred million in the next few years.  This stock has tremendous potential and we believe could trade easily over one dollar per share by the end of 2015.


Enzo Biochem ( ENZ  3.04 )  Bought at our price of  $ 2.78..


This turbulent market has had an effect on the price of Enzo Biochem. The markets, in my opinion, have been in a rotating correction and in some instances, a bear market for some months. It appears that the cause of this is China but I am sure that there are other factors. If you remember the ‘flash crash” of 2010  the market correction was over quickly and those that held through that market decline profited handsomely over the years after the crash. I think that the market is giving us another chance to buy Enzo Biochem at a bargain price. The Company’s fiscal year was over July 31. I would imagine the Quarter and Year results will be made available by mid-October. With the cash settlement in two litigations the cash position should show a major improvement. Top line revenues should also show an improvement. Depending on R&D expenses and litigation expenses the net loss should also show improvement. At today’s price of $2.90 the Company is valued at approximately $130 million and with revenues approaching $100 million or 1.3 times revenues. The last Craig Hallum report had a fair value of Enzo’s business of $6 per share. When AmpiProbe is approved and into the market that number is projected at $14 per share. There is always risk in the market so the investment is not without risk but if held over time should deliver handsome profits off of today’s price. Items to look forward to by the end of the year would be litigation news and an AmpiProbe decision all of which should have a positive impact on the stock price.


Premier Holding Corporation ( PRHL: 0.06 )* 

Volume on Friday 27,200 shares. Shares Outstanding  189,218,861 


We initiate coverage of the Premier Holding Corporation with an immediate target of $ 0.65, which would be 10x the current closing price which was also the bid price offered mostly at $ 0.07. The deregulated energy business is estimated to be a $ 500 billion+ industry in the U.S. and is estimated to be 5-7 times larger than the lucrative telecom deregulation market launched in the early 1980’s.


According to the U.S. Energy Information Administration the deregulated retail electric supply market in the northeast alone is over $ 75 billion annually and the current New York market is approximately $ 7.7 billion.


In February 2013 they purchased 80% of the Power Company ( “TPC” ) which is in the deregulated energy space, a $ 500 billion market. The company offers electricity and gas to consumers in the deregulated energy markets. PRHL through its subsidiaries accumulates residential and commercial clients in deregulated markets from all subsidiaries and cross sells energy and energy efficient products and services. I addition PRHL provides top management and financial support services.


They provide two basic deliverables to clients:

  • Energy alternatives brought about by deregulation that results in lower cost energy and
  • Offer energy efficient solutions that provide savings through utilization of state of the art technologies.


When Premier acquired TPC, they had sold 11,000 energy contracts. Today that number is over 100,000 contracts. ( Residential Equivalent Contracts ) On October 28,2014 Premier acquired 85% of Lexington Power and Light, LP&L, which became the third subsidiary.


LP&L receivables are guaranteed by the utility.




Stocks and ETF’s bought over the past few weeks


The  HDGE declined last week to 11.23 its lowest close since the break-out above 11.04 which was the buy signal and an opportunity to make money while the markets are plummeting.  We bought the HDGE @ 11.04.  HDGE is the BEAR hedge.


We   were  unable to buy  Golar.  We bought  Mosaic  MOS and were stopped out at $ 41.90 for a loss of $ 110 plus commissions.  We  were able to buy  Southwest Air  (LUV ) at 33 and Harley Davidson ( HOG ) at  54.   We bought  Virgin Air ( VA ) at 32.20.


Please check on the previous weekly market letters if there are  questions.


We are long in Diana Shipping at 6.60.  DSX  is looking better and you should  buy now if not  already long .


We bought Bank of America  and continue to like the banking sector.


Symbol Name Business Description PE



P/S MV mln Price Buy Limit Stop Loss

Or sold

VA Virgin Air Regional Airlines 7.2 1.0 1.5B 34.78 32.20 29.50
MOS Mosaic Fertilizer 14.6 1.70 15.68B 39.14 43.00 41.90x
OSIR Osirus Therapeutics Biotechnology 690 9.06 664M 19.32 18.90 18.50 x

Stopped out

LUV Southwest Air Regional Airlines 16 1.15 22.6B 38.54 33 32.31sco
HOG Harley Davidson Consumer Goods 14 1.87 11.6B 54.78 54 52.39sco
ENZ Enzo Biochem Life Sciences NA 1.35 134M  3.04 2.78 2.44x
BAC Bank of America Commercial Bank 10 2.02 165.3B 16.04 16.45 15.22x
HDGE Advisor Shares Ranger Bear ETF 11.23 11.04 X 11.00X
GLNG Golar Liquefied N.G. Hedging NA 30.39 3.14B 35.47 32.44 30.50
DSX Diana Shipping Dry Cargo Shipping N/A 3.7 611  6.18 6.60 5.90


For Free Where To Invest Your Money Now

High Return Investments Trade Alerts

Go To: PrincetonResearch.com/alerts.htm


NOTE: This is a Sample Issue Only!




Visit: PrincetonResearch.com/join.htm


Rule 17B Attestations and Disclaimers


Princeton Research, Inc. has approximately 2,581,578 shares of AIVN both free and restricted and represents them for Investor relations. Princeton also has about 40,000 shares of TXGE. Princeton is paid $ 1,500 per month from RMS Medical Products. Princeton has bought 81,100 shares of RMS Medical Products. Princeton was paid $ 2,500 to write a report on Xinergy. Princeton has signed a contract with CBLI to be paid $ 2500 for July and August for investor relations. Princeton has been engaged by Target Energy. No contract is currently in place. Princeton was paid about 500,000 restricted shares of Leo Motors.


When there is no movement in penny stocks, even though there is none or very small losses, we will liquidate ( sold AIVN on stop ) even though we like the company, if money is needed for better opportunities.


We now believe REPR represents upside opportunity. The Target ADR trades at about $ 4.50 in U.S. vs 0.05 in Australia. Princeton owns 400,000 Australia shares and about 900 U.S. ADR’s.


Pursuant to the provisions of Rule 206 (4) of the Investment Advisers Act of 1940, readers should recognize that not all recommendations made in the future will be profitable or will equal the performance of any recommendations referred to in this e-mail issue. Princeton may buy or sell its free-trading shares in companies it represents at any time.





Please Direct All Inquiries To:


Mike King

(702) 650-3000



Charles Moskowitz

 (781) 826-8882



Princeton Research

3887 Pacific Street,

Las Vegas, Nevada 89121




Options Trading Strategies